Latest News & Updates

Breaking News

  • 5 hours ago

  • Pharma Now Editorial Team

Novartis Multi-Asset Launch Wave Tests CMC and Supply Chain Limits
Breaking News
Survodutide Phase III Data Sharpens GLP-1 Supply Chain Pressure

Pharma Now Editorial Team

Other trending news you may like to read

Novartis Multi-Asset Launch Wave Tests CMC and Supply Chain Limits

Novartis Q1 2026 regulatory milestones across immunology and neuromuscular assets signal mounting CMC and supply chain demands for the remainder of the year.

Pharma Now Editorial Team

Pharma Now

Survodutide Phase III Data Sharpens GLP-1 Supply Chain Pressure

Survodutide hits Phase III co-primary endpoints with 16.6% weight loss, intensifying manufacturing and regulatory planning demands.

Pharma Now Editorial Team

Pharma Now

Piramal Pharma Solutions Targets European Biologics CDMO Growth

Piramal Pharma Solutions appoints Gregory Judge as Director to lead large-molecule biologics partnerships across Europe.

Pharma Now Editorial Team

Pharma Now

92 US Biosimilar Approvals Reshape Manufacturer Strategy in 2026

Samsung Bioepis Q2 2026 report records 92 US biosimilar approvals, signaling tighter interchangeability and QA demands for manufacturers.

Pharma Now Editorial Team

Pharma Now